Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Multiple indications for anti-inflammatory apolipoprotein mimetic peptides Van Lenten BJ; Navab M; Anantharamaiah GM; Buga GM; Reddy ST; Fogelman AMCurr Opin Investig Drugs 2008[Nov]; 9 (11): 1157-62Apolipoprotein mimetic peptides dramatically reduce atherosclerosis in animal models, and may be an excellent mode of therapy to treat a variety of vascular inflammatory conditions, including atherosclerosis. Studies of apolipoprotein mimetic peptides in models of inflammatory disorders other than atherosclerosis, including viral influenza, asthma, chronic rejection after heart transplantation, sickle cell disease, scleroderma, diabetes, cognitive dysfunction and renal inflammation, suggest that apolipoprotein mimetic peptides may have efficacy in a wide range of inflammatory conditions.|Anemia, Sickle Cell/drug therapy[MESH]|Animals[MESH]|Anti-Inflammatory Agents/*therapeutic use[MESH]|Apolipoprotein A-I/*therapeutic use[MESH]|Asthma/drug therapy[MESH]|Atherosclerosis/drug therapy[MESH]|Diabetes Mellitus/drug therapy[MESH]|Graft Rejection/drug therapy[MESH]|Heart Transplantation/adverse effects[MESH]|Humans[MESH]|Nephritis/drug therapy[MESH] |
